This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
between 25 and 35
years old
This is an early phase trial to investigate
how or whether the drug affects your body.
Show me locations

The purpose

The aim of this study is to assess the role of AMH in prediction of poor ovarian response as well as the relation between ESR2 (+1730G>A) (rs4986938), FSHR p.Thr307Ala (c.919A>G, rs6165) and FSHR p.Asn680Ser (c.2039A>G, rs6166) SNPs and the poor response in Egyptian women undergoing IVF procedure. Discovering the genetic variants associated with ovarian response is an important step towards individualized pharmacogenetic protocols of ovarian stimulation.

Provided treatments

  • Drug: Human menopausal gonadotrophin (HMG)
  • Drug: GnRH antagonist Cetrorelix
  • Drug: Human chorionic gonadotrophin (hCG)

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02640976. The sponsor of the trial is Cairo University and it is looking for 216 volunteers for the current phase.
Official trial title:
Assessing the Relation Between Hormone Receptors Gene Polymorphism and Ovarian Stimulation Response in In Vitro Fertilization (IVF) Program